Tower Research Capital LLC (Trc) Pulse Biosciences, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 854 shares of PLSE stock, worth $15,628. This represents 0.0% of its overall portfolio holdings.
Number of Shares
854
Previous 2,285
62.63%
Holding current value
$15,628
Previous $25,000
44.0%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding PLSE
# of Institutions
77Shares Held
5.41MCall Options Held
139KPut Options Held
84.2K-
Black Rock Inc. New York, NY1.15MShares$21 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA996KShares$18.2 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC786KShares$14.4 Million0.0% of portfolio
-
State Street Corp Boston, MA461KShares$8.44 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA457KShares$8.37 Million0.0% of portfolio
About Pulse Biosciences, Inc.
- Ticker PLSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,125,900
- Market Cap $679M
- Description
- Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...